Corona Remedies Ltd
- Market Cap ₹ 6,495 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 43.3
- Book Value ₹
- Dividend Yield %
- ROCE 31.5 %
- ROE 27.6 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 25.0%
Cons
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 884 | 1,014 | 1,196 | |
| 756 | 859 | 956 | |
| Operating Profit | 128 | 156 | 241 |
| OPM % | 14% | 15% | 20% |
| 7 | 5 | 6 | |
| Interest | 4 | 14 | 11 |
| Depreciation | 20 | 28 | 37 |
| Profit before tax | 111 | 118 | 199 |
| Tax % | 23% | 24% | 25% |
| 85 | 90 | 149 | |
| EPS in Rs | 13.89 | 14.80 | 24.43 |
| Dividend Payout % | 20% | 25% | 30% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 64% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 28% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 61 | 61 | 61 |
| Reserves | 347 | 419 | 545 |
| 28 | 159 | 86 | |
| 159 | 191 | 237 | |
| Total Liabilities | 595 | 831 | 930 |
| 185 | 384 | 370 | |
| CWIP | 65 | 121 | 186 |
| Investments | 32 | 26 | 26 |
| 314 | 301 | 348 | |
| Total Assets | 595 | 831 | 930 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 103 | 157 | 190 | |
| -50 | -267 | -84 | |
| -45 | 99 | -107 | |
| Net Cash Flow | 8 | -11 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 36 | 36 | 36 |
| Inventory Days | 182 | 158 | 200 |
| Days Payable | 163 | 184 | 221 |
| Cash Conversion Cycle | 55 | 10 | 14 |
| Working Capital Days | 30 | -2 | 9 |
| ROCE % | 25% | 32% |
Documents
Announcements
No data available.